- World rank, all time
- #15,893 of 42,892
- Rank in United Kingdom
- #859 of 2,253
- Research works
- 228 ▲ 62% vs 2013–17
- Citations
- 8.9k 39.0 per fractional work
- Top-10% rate
- 30.3% record average 16.5%
- Open access
- 37% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 20.4×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 20.4×
- Immunology and Microbiology 5.8×
- Chemistry 5.8×
- Biochemistry, Genetics and Molecular Biology 5.8×
- Medicine 1.6×
- Veterinary 1.3×
- Materials Science 1.1×
- Computer Science 1.0×
- Neuroscience 0.6×
- Decision Sciences 0.5×
- Physics and Astronomy 0.4×
- Economics, Econometrics and Finance 0.1×
- Agricultural and Biological Sciences 0.1×
- Engineering 0.0×
- Health Professions 0.0×
Who are the top researchers at Evotec (United Kingdom)?
Ranked on the composite score, Mark Whittaker and Heather Tye lead among researchers whose main affiliation is Evotec (United Kingdom).
- 1 Mark Whittaker · #172,524 worldwide 240 citations · 36 works
- 2 Heather Tye · #1,537,939 worldwide 45 citations · 16 works
Which keywords describe research at Evotec (United Kingdom)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Pharmacokinetics, Molecular Docking, Oxidative Stress, Medicinal Chemistry, Metabolic Regulation, Drug Target Identification, Virtual Screening and Machine Learning.
- Tumor Microenvironment
- Glycosylation
- Treatment
- Therapeutic Antibodies
- Mitochondrial Dysfunction
- Immunity
- Molecular Dynamics
- Epidemiology
- Pharmacogenetics
- Cytochrome P450
- Drug Metabolism
- Cognitive Function
- Multidrug Resistance
- Virtual Screening
- Drug Target Identification
- Molecular Docking
- Machine Learning
- Pharmacokinetics
- Oxidative Stress
- Medicinal Chemistry
- Metabolic Regulation
- ATP-dependent Transporters
- Cancer
- Antiepileptic Drugs
- Prenatal Exposure
- Drug Discovery
- Inflammation
- Cancer Therapy
- Cell Signaling
- Antibiotic Resistance
- Monoclonal Antibodies
- Transcriptional Regulation
- Cancer Immunotherapy
- Metabolic Disorders
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 34 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 34 words, with their numbers
- Pharmacokinetics5▲ 41×3 topics
- Machine Learning4▲ 2.9×5 topics
- Oxidative Stress4▲ 5.4×11 topics
- Molecular Docking4▲ 61×3 topics
- Medicinal Chemistry3▲ 27×4 topics
- Drug Target Identification3▲ 67×1 topic
- Metabolic Regulation3▲ 39×3 topics
- Virtual Screening3▲ 67×1 topic
- ATP-dependent Transporters3▲ 229×1 topic
- Multidrug Resistance3▲ 173×1 topic
- Cancer2▲ 4.1×13 topics
- Cognitive Function2▲ 28×2 topics
- Antiepileptic Drugs2▲ 62×1 topic
- Drug Metabolism2▲ 176×2 topics
- Prenatal Exposure2▲ 157×1 topic
- Cytochrome P4502▲ 132×1 topic
- Drug Discovery2▲ 20×5 topics
- Pharmacogenetics2▲ 222×1 topic
- Inflammation2▲ 1.90×10 topics
- Epidemiology2◆ 0.95×10 topics
- Cancer Therapy2▲ 5.8×8 topics
- Molecular Dynamics2▲ 20×2 topics
- Cell Signaling1▲ 18×5 topics
- Immunity1▲ 7.0×4 topics
- Antibiotic Resistance1▲ 6.8×3 topics
- Mitochondrial Dysfunction1▲ 9.0×5 topics
- Monoclonal Antibodies1▲ 30×2 topics
- Therapeutic Antibodies1▲ 38×2 topics
- Transcriptional Regulation1▲ 17×5 topics
- Treatment1▲ 2.2×4 topics
- Cancer Immunotherapy1▲ 15×3 topics
- Glycosylation1▲ 21×3 topics
- Metabolic Disorders1▲ 19×2 topics
- Tumor Microenvironment1▲ 5.0×5 topics
Which research topics does Evotec (United Kingdom) publish most on?
By volume in 2022–2025: Computational Drug Discovery Methods, Drug Transport and Resistance Mechanisms, Pharmacological Effects and Toxicity Studies and Pharmacogenetics and Drug Metabolism.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Computational Drug Discovery Methods Computational Theory and Mathematics 3 works
- 2 Drug Transport and Resistance Mechanisms Oncology 3 works
- 3 Pharmacological Effects and Toxicity Studies Pediatrics, Perinatology and Child Health 2 works
- 4 Pharmacogenetics and Drug Metabolism Pharmacology 2 works
- 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 6 Machine Learning in Materials Science Materials Chemistry 1 works
- 7 RNA Interference and Gene Delivery Molecular Biology 1 works
- 8 Protein Degradation and Inhibitors Molecular Biology 1 works
- 9 Biomedical Text Mining and Ontologies Molecular Biology 1 works
- 10 Bioinformatics and Genomic Networks Molecular Biology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Evotec (United Kingdom)'s research output changed?
Output in 2018–2022 was 62% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Abingdon
- United Kingdom Atomic Energy Authority
- Culham Science Centre
- Culham Centre for Fusion Energy
- Oxford Instruments (United Kingdom)
- Summit (United Kingdom)
- Immunocore (United Kingdom)
- Tokamak Energy (United Kingdom)
- Adaptimmune (United Kingdom)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.